Characterization of SARS‐CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence‐based assay

[1]  Jiahai Shi,et al.  Dissection Study on the Severe Acute Respiratory Syndrome 3C-like Protease Reveals the Critical Role of the Extra Domain in Dimerization of the Enzyme , 2004, Journal of Biological Chemistry.

[2]  J. Hsu,et al.  Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate , 2004, Biochemical and Biophysical Research Communications.

[3]  A. Velázquez‐Campoy,et al.  Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. , 2004, Biochemistry.

[4]  Mayuko Takeda-Shitaka,et al.  Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design. , 2004, Chemical & pharmaceutical bulletin.

[5]  Y. Liu,et al.  3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism. , 2004, Biochemistry.

[6]  Xue Wu Zhang,et al.  Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design , 2004, Bioorganic & Medicinal Chemistry.

[7]  Andreas Koeller,et al.  Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design. , 2004, Journal of medicinal chemistry.

[8]  Luhua Lai,et al.  Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase , 2004, Journal of Biological Chemistry.

[9]  G. Gao,et al.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Scott D. Kahn,et al.  Assessment of putative protein targets derived from the SARS genome , 2003, FEBS Letters.

[11]  Kaixian Chen,et al.  Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus , 2003, Protein Expression and Purification.

[12]  Ram Samudrala,et al.  Identifying inhibitors of the SARS coronavirus proteinase , 2003, Bioorganic & Medicinal Chemistry Letters.

[13]  Rolf Hilgenfeld,et al.  Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.

[14]  Cheng Luo,et al.  A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. , 2003, Acta pharmacologica Sinica.

[15]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[16]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[17]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[18]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[19]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[20]  D. Norbeck,et al.  Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. , 1999, Archives of biochemistry and biophysics.

[21]  Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. , 1996, Journal of medicinal chemistry.

[22]  B. Dunn,et al.  A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate. , 1995, Analytical biochemistry.

[23]  C. Dolea,et al.  World Health Organization , 1949, International Organization.